Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
ALS Drug May Improve Outcomes for Those With Advanced Melanoma
A drug that is used primarily to treat ALS may also have benefits for patients with melanoma. Find out exactly what this drug is, and more details from the related study.
A drug that is used primarily to treat ALS may also have benefits for patients with melanoma. Find out exactly what this drug is, and more details from the related study.
Inhibitor Combo Reduces Death by One-Third in Melanoma
A recent trial shows that a combination of inhibitors may prove effective in the treatment of skin cancer. Full results of the study are included here.
A recent trial shows that a combination of inhibitors may prove effective in the treatment of skin cancer. Full results of the study are included here.
Counteracting Drug Resistance in Melanoma
While treating melanoma, many patients undergo effective treatment, but can then end up resistant to future inhibitor therapy. See which combination causes this, and how to potentially avoid it in the future.
While treating melanoma, many patients undergo effective treatment, but can then end up resistant to future inhibitor therapy. See which combination causes this, and how to potentially avoid it in the future.
NEW YORK (Reuters) - A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be ...
... solution for cancer research and other valuable human applications. ... cancer therapy to adhere to cancer cells, allowing the immune system to do ...
Vitamins play a vital role in the strengthening of immune system and are very ... They can also lower the risk to development of some cancer diseases.
Cancer in any form is terrifying, but an aggressive form of skin cancer ... having a weakened immune system as other factors which could influence ...
Wasting doctor's time and fearing the worst are given as reasons why half of over-50s ignore symptoms
British 'stiff upper lip' means nearly half over 50s ignore cancer symptoms
Further reasons include fearing the worst and dismissing warning signs
People also lack confidence in the country's health care system
Study by Cancer Research looked at more than 1,700 people 50 and over
In both studies, one evaluating patients with bladder cancer and the other evaluating patients with non-small cell lung cancer (NSCLC), investigators ...
According to the American Cancer Society, bladder cancer is the fifth most common cancer in the US with approximately 75,000 new cases in 2014 ...
Schistosomiasis, for example, which affects an estimated 240 million people globally, is a known risk factor for bladder cancer- accounting for up to ...
However, in the case of cancer, we want to block these “checkpoints” at pathways to make the immune system as active as it can be against breast ...
Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug ...
Cancer immunotherapy, which is based on the concept of using the body's immune system to fight cancer, was voted by the renowned Science journal ...
Immunotherapy, defined by the American Cancer Society as a treatment that uses certain parts of the immune system to fight diseases such as cancer, ...
... Phase III head and neck cancer trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin Injection) in Romania.
An Epstein-Barr virus erupting from an infected immune cell, called a B lymphocyte. Image: Analytical Imaging Facility at the Albert Einstein College of ...
By acting together, these hybrid cancer cells have a better chance to evade the immune system during migration and can better survive while ...
Ottawa woman says mistletoe helped her recover from cancer ... can help boost the immune system and improve quality of life for cancer patients.
Hodgkin's Lymphoma is a cancer of the immune system that typically includes “enlargement of the lymph nodes, spleen and other immune tissue,” ...
Cancer News in Science Daily
Scientists have revealed how a type of cancer-causing virus outwits the human body's immune response. The discovery might help explain why some cancer therapies that incorporate interferon fail to treat certain cancers and might lead to more effective treatments.
A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the current screening standard.
At 18 months median follow up of a phase 1 clinical trial, one patient's cancer had worsened, two had died, and nine remained free of disease. Testing of blood and tumor samples showed that CUDC-101 had indeed inhibited the action of EGFR, HDAC and Her2.
Three of the four most fatal cancers are caused by a protein known as Ras; either because it mutates or simply because it ends up in the wrong place at the wrong time. Ras has proven an elusive target for scientist trying to cure the deadly diseases. Now a group of researchers has discovered an unknown way for RAS to find its proper place in the cell. Their discovery may lead to completely novel approaches to curing cancer.
Targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer, researchers report. Cancer cells undergo metabolic alterations to meet the increased energy demands that support their excess growth and survival. The Krebs cycle in the mitochondria of cells is used to supply both energy and building materials for cell growth. Two mitochondrial enzymes -- pyruvate carboxylase (PC) and glutaminase replenish carbon to the Krebs cycle.
Biophysicists reveal how cancer uses notch-signaling pathways to promote metastasis. Their computer models provide a fresh theoretical framework for scientists who study ways to target cancer progression.
The spontaneous PSA testing that has been applied in Sweden in recent decades has only had a marginal effect on mortality. An organized screening focused on those who have the most to gain would, however, reduce the risk of dying from prostate cancer by over 40 percent, researchers suggest.
A new analysis has found that many women with breast cancer lack knowledge about their illness, with minority patients less likely than white patients to know and report accurate information about their tumors' characteristics. The findings highlight the need to educate patients about their health conditions, which could lead to more informed treatment decisions.
Nanodiamonds: Promising use for delivering cancer drug to kill chemoresistant cancer stem cells more effectively
Delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer, researchers report after the conclusion of their study.
Tambahkan Komentar